Advertisement

Advertisement

HotelsFoodShoppingCoffeeGroceryGas

Connect Biopharma

Website

Advertisement

Advertisement

12265 El Camino Real Ste 350
San Diego, CA 92130
https://www.connectbiopharm.com

Connect Biopharma is a global biopharmaceutical company based in San Diego, California, with additional offices in Taicang, China. They are dedicated to improving the lives of patients with chronic inflammatory diseases through the development of innovative therapies derived from T cell-driven research.

With their expertise in Th2 biology and proprietary Immune Modulation Technology Platform, Connect Biopharma aims to discover novel small molecules and biologics that have the potential to be best- and first-in-class therapies for serious autoimmune and inflammatory diseases with significant unmet medical needs.

Generated from the website

Also at this address

Robert Chang, ATY - Jones Day

Keller Williams Realty Carmel

New Vista Asset Management

California BanCorp

Own this business?
Claim it
See a problem?

You might also like

Oncternal Therapeutics, Inc
Cancer detection program administration, government, Cancer hospital, Sizes

Oncternal Therapeutics, Inc

GTx is a biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutics primarily related to the treatment of serious men s health conditions and oncology. Its drug discovery and development programs are focused on small molecules that selectively modulate the effects of estrogens and androgens. In addition, the company has a marketed product and nearly five clinical programs. GTx also has an extensive preclinical pipeline generated from its own discovery program, which includes the specific product candidates prostarine and andromustine. GTx has a location in Memphis, Tenn.
Drugs acting on the respiratory system

Medvantx

Medvantx Pharmacy is a trusted and award-winning pharmacy services provider based in San Diego, CA. They specialize in connecting patients, healthcare providers, and pharmaceutical manufacturers to enhance access to affordable medications through their Patient Assistance Programs, Cash Pay solutions, and comprehensive Pharmacy Services. With over 10 years of experience, Medvantx operates two nationally licensed mail order pharmacies, offering world-class fulfillment and medication management solutions, ensuring patients receive the medications they need with extended accessibility and privacy. Through their proprietary Medvantx Insights Platform, which combines consultancy expertise and advanced technology solutions, Medvantx provides accurate and efficient medication delivery, prescription verification, patient counseling, and education. They are committed to improving patient health outcomes by eliminating financial barriers through their patient assistance programs, bridge and quick start programs, and product replacement services. Medvantx is a trusted partner with nationwide scale, serving clients across the United States and territories, and has been recognized with prestigious awards in the pharmaceutical and healthcare industry for their commitment to leadership and increasing access to medications for patients nationwide.Generated from the website
Drugs acting on the respiratory system, Vitamin, nutrient, and hematinic preparations for human use, Drugs and drug proprietaries

Gyre Therapeutics, Inc

Targacept is a biopharmaceutical company engaged in the design, discovery and development of a new class of drugs to treat diseases and disorders of the central nervous system. It is a leader in the field of neuronal nicotinic acetylcholine receptor chemistry and biology. NNRs are found on nerve cells throughout the nervous system and serve as key regulators of nervous system activity. Targacept s product candidates are designed to selectively target specific NNR subtypes and promote therapeutic effects and limit adverse side effects. Targacept has product candidates in clinical development for cognitive impairment, including Alzheimer s disease and age-associated memory impairment, pain and depression. From 1997 to 2000, Targacept was a subsidiary of R. J. Reynolds Tobacco Company. During this time, the company s investigations into the biological effects of nicotine suggested a role for NNRs in the treatment of human disease and led to the creation of Targacept.
United States›California›San Diego›Connect Biopharma

Partial Data by Infogroup (c) 2024. All rights reserved.

Advertisement

Advertisement

  • Get directions
  • MapQuest Travel
  • Route Planner
  • Print your map
  • Get help
  • Search the web
  • Send feedback
Learn more about our mobile apps.
  • Android app Google Play
  • Download on the App Store
  • Download on the Amazon Appstore
  • Enterprise solutions
  • Claim your business
  • Developer resources
  • Jobs
  • Advertise with us
  • Terms of use
  • Privacy policy
  • Data and licenses
  • About our ads
  • Do not sell